Arimistane Spectre Labs: Compound Profile
Arimistane is a naturally occurring aromatase inhibitor and steroid metabolite classified within the androsta-3,5-diene-7,17-dione family. This compound functions as an irreversible inhibitor of the aromatase enzyme (CYP19A1), which catalyses the conversion of androgens to estrogens. Researchers at Stroid UK Shop frequently investigate Arimistane’s mechanisms for understanding estrogen biosynthesis pathways and hormonal regulation in laboratory models. The compound’s unique molecular structure allows for comprehensive examination of enzyme inhibition kinetics and downstream hormonal effects in controlled experimental environments.
Laboratory Applications
Scientific investigations utilise Arimistane to study aromatase enzyme inhibition patterns and estrogen-dependent cellular processes. Researchers examine this compound’s effects on steroidogenesis pathways, particularly focusing on its irreversible binding characteristics with the aromatase enzyme. Studies in our androsta-3,5-diene-7,17-dione category demonstrate its utility in hormonal research protocols. Laboratory teams investigate Arimistane alongside other research compounds including those found in our SARMs collection and peptide research materials to understand complex hormonal interactions. The compound’s stability and purity make it suitable for extended research protocols examining endocrine system modulation.
Technical Specifications
| Parameter | Specification |
|---|---|
| Chemical Name | Androsta-3,5-diene-7,17-dione |
| Molecular Weight | 270.37 g/mol |
| Purity | ≥99% |
| Storage Temperature | Room temperature, dry conditions |
| Solubility | Verify with supplier |
| CAS Number | Verify with supplier |
| Form | Crystalline powder |
| Manufacturer | Spectre Labs |
Research Compliance
This Arimistane product is manufactured by Spectre Labs exclusively for in-vitro laboratory research purposes. The compound is not intended for human consumption, therapeutic use, or any application outside controlled scientific investigation. Researchers must maintain appropriate laboratory safety protocols and comply with institutional guidelines when handling this material. All studies should be conducted by qualified personnel in properly equipped research facilities with adequate ventilation and safety measures.
